A Phase 1 Study Of Cc-92480, A Novel Celmod Agent, In Patients With Relapsed/Refractory Multiple Myeloma: Pharmacodynamic Effects Of Dose And Schedule
Lilly Wong,Manisha Lamba,Maria Dolores Jimenez Nunez,Daniel Bauer,Nizar J. Bahlis,Annette J. Vangsted,Karthik Ramasamy,Suzanne Trudel,Joaquin Martinez-Lopez,Maria-Victoria Mateos,Paula Rodriguez Otero,Sagar Lonial,Rakesh Popat,Albert Oriol,Chatchada Karanes,Robert Z. Orlowski,Jesus G. Berdeja,Michael Pourdehnad,Daniel W. Pierce,Paul G. Richardson BRITISH JOURNAL OF HAEMATOLOGY（2021）
AI 理解论文
溯源树
样例
